A Microsphere-Based Vaccine Prevents and Reverses New-Onset Autoimmune Diabetes | Zendy

Brett E. Phillips | Zendy; Karen D. Nylander | Zendy; Jo Harnaha | Zendy; Jennifer Machen | Zendy; Robert Lakomy | Zendy; Alexis Styche | Zendy; Kimberly Gillis | Zendy; L. R. Brown | Zendy; Debra Lafreniere | Zendy; Michael Gallo | Zendy; Janet Knox | Zendy; Kenneth Hogeland | Zendy; Massimo Trucco | Zendy; Nick Giannoukakis | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

A Microsphere-Based Vaccine Prevents and Reverses New-Onset Autoimmune Diabetes

Author(s) -

Brett E. Phillips,

Karen D. Nylander,

Jo Harnaha,

Jennifer Machen,

Robert Lakomy,

Alexis Styche,

Kimberly Gillis,

L. R. Brown,

Debra Lafreniere,

Michael Gallo,

Janet Knox,

Kenneth Hogeland,

Massimo Trucco,

Nick Giannoukakis

Publication year - 2008

Publication title -

diabetes

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.219

H-Index - 330

eISSN - 1939-327X

pISSN - 0012-1797

DOI - 10.2337/db07-0507

Subject(s) - nod mice , foxp3 , nod , cd80 , splenocyte , spleen , immunology , medicine , adoptive cell transfer , immune system , cd86 , t cell , antigen , diabetes mellitus , cd40 , biology , endocrinology , cytotoxic t cell , autoimmunity , in vitro , biochemistry

This study was aimed at ascertaining the efficacy of antisense oligonucleotide-formulated microspheres to prevent type 1 diabetes and to reverse new-onset disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research